Trial
NCT03242772
Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
Autism Spectrum Disorder
Intervention
Amphetamine
Why stopped
The study stopped recruitment of new participants due to COVID. A substudy was developed with adaptations to the main design.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-22